G

Genomics England

Provides NHS genomic testing and research.

Principal Product Manager

Full-TimeUpdated on 10/20/2026Deadline 11/1/26
£95.5k
Expert
London, UK
HybridOffice attendance is expected at least twice monthly; days may vary by role and team.
ProductProduct Management

About the job

Requirements
  • Demonstrable track record of leading complex product areas at Principal Product Manager level or equivalent.
  • Substantial and direct product management experience, including a strong record of leading complex products, services or product areas.
  • Experience shaping product vision, strategy, outcomes and roadmaps across complex product areas, translating strategic direction into focused action.
  • Deep experience leading discovery, including framing ambiguous problems, gathering requirements, using research and evidence to test assumptions, and making confident product decisions.
  • Strong understanding of user-centred product development, combining user insight and qualitative and quantitative data to shape priorities and measure impact.
  • Experience leading across multiple teams, disciplines or products, creating alignment, managing dependencies and making thoughtful trade-offs.
  • Ability to communicate complex choices clearly, constructively challenge assumptions and build trust across organisational boundaries.
  • Sound judgement in balancing user value, organisational priorities, feasibility, risk and sustainability, particularly where decisions are complex or sensitive.
  • Experience leading through the full product lifecycle, from discovery and proposition development through delivery, adoption and continuous improvement.
  • Collaborative approach to product leadership, including mentoring Product Managers and helping strengthen product practice.
  • Ability to provide strategic product leadership, set direction amid ambiguity and influence across teams and organisational boundaries.
  • Successful candidates must undergo a Standard Disclosure and Barring Service check and disclose previous offences at application; some unspent convictions may prevent progression.
  • Applicants may request adjustments to participate fully in the recruitment process.
Responsibilities
  • Lead a strategically important product area, setting its vision, strategy and intended outcomes while coordinating work across related products, services and squads.
  • Set meaningful OKRs aligned with wider programme and organisational priorities, translating them into coherent roadmaps and focused backlogs.
  • Lead discovery from its earliest stages by framing complex and ambiguous problems, gathering requirements, testing assumptions and using research, experimentation and evidence to determine team focus.
  • Lead products and services across their full lifecycle, adapting direction as evidence, user needs and products evolve.
  • Bring together user insight, qualitative and quantitative data, and relevant operational, technical, scientific, clinical and regulatory context to inform product decisions and measure impact.
  • Work across user research, design, engineering, data, delivery, operations, governance and policy to create shared understanding, align priorities and manage dependencies across squads.
  • Make transparent prioritisation and trade-off decisions that balance participant needs, strategic value, feasibility, delivery constraints, risk and regulatory responsibilities.
  • Build trusted relationships with senior internal and external stakeholders, communicate direction clearly, constructively challenge assumptions and create conditions for cross-functional teams to succeed.
  • Partner with the programme lead to set vision, strategy and intended outcomes, and support leadership of the wider team, deputising for the programme lead when required.
  • Connect related work, manage complex dependencies and help teams make effective product decisions while staying close to delivery to identify where support, challenge or intervention is needed.
  • Play a leadership role in the wider product management chapter, owning cross-chapter initiatives, mentoring Product Managers and helping drive excellent practice across teams.
  • Initially lead the team through early discovery product work, with a view to shaping delivery later.
  • Help shape how Genomics England handles participant needs, choices and data responsibly throughout the product lifecycle.
Desired Qualifications
  • Experience working with sensitive data or in healthcare, life sciences, government, financial services or another highly regulated environment.
  • Experience working on know-your-customer work.
  • Experience with products or services involving participant, patient, citizen or customer consent, preferences and ongoing engagement.
  • Experience with healthcare, clinical research, genomics, or data-intensive scientific infrastructure and software.
  • Experience with products that support the responsible access, stewardship or secondary use of sensitive data.
  • Experience working within complex governance, assurance, ethical or regulatory frameworks.

About the company

Genomics England works with the NHS to bring genomic healthcare and research to Britain, including genomic testing as part of routine care and the data/tech researchers need. It runs a national program to collect and analyze genetic data, comparing genomes to support diagnosis, treatment, and prevention and to power discoveries. Its approach combines a government-backed national effort with NHS clinical care, building a large, unique genomic dataset and turning findings into real-world tools. Its goal is to bring genomic healthcare to everyone who needs it, while speeding up research and enabling more precise treatments.

Company Size

501-1,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$277.2M

Headquarters

London, United Kingdom

Founded

2013

Get referred to Genomics England

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 2026 Lifebit contract modernizes research access and targets researcher availability in 2027.
  • AWS said August 2026 FinOps work saved Genomics England over £1 million yearly.
  • Revvity expanded its Generation Study collaboration in March 2025, adding sequencing services.

What critics are saying

  • Nicola Blackwood exits as Chair in late 2026, forcing a governance transition.
  • Long procurement cycles and 2027 platform delivery risk slowing researcher adoption and output.
  • Any major data-trust breach would cripple NHS participation and jeopardize Genomics England's mandate.

What makes Genomics England unique

  • UK government-owned, Genomics England controls the National Genomic Research Library and NHS sequencing.
  • Its secure research environment keeps participant-level data inside the perimeter, enabling approved analysis.
  • It combines rare-disease, cancer, and newborn sequencing programs with national-scale consented data.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Health Savings Account/Flexible Spending Account
  • Unlimited Paid Time Off
  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Genomics England
Jul 2nd, 2026
Genomics England selects Lifebit for enhanced research environment to enable cutting-edge genomic research.

Genomics England selects Lifebit for enhanced research environment to enable cutting-edge genomic research. 2 Jul 2026 Genomics England is working with Lifebit to develop a next-generation research environment to support research into rare conditions and cancer. To meet growing research potential and demand, Genomics England has procured an enhanced research environment with improved capability. This will support more complex analysis, improve usability for researchers, and help accelerate the translation of scientific discoveries into healthcare. Following a rigorous procurement process, Lifebit has been selected to deliver the platform, drawing on its experience developing secure infrastructure for large-scale analysis of sensitive health data. Advances in genomic research increasingly depend on the ability to analyse large, complex datasets across many genes and participants. Strengthening the underlying infrastructure is therefore critical to ensuring researchers can make full use of the data and generate meaningful insights, and fully exploit the benefits of AI. Genomics England is a UK government-owned organisation that delivers whole genome sequencing diagnostics through the NHS. Alongside this, it runs its own major research initiatives and enables research using consented and de-identified genomic and health data held in the National Genomic Research Library. This resource supports scientific discovery and the development of new therapies, with the aim of improving outcomes for patients. Access to this data is provided through a research environment - a secure, centralised platform where approved researchers can analyse data without it leaving the system. The UK government has emphasised the importance of genomic healthcare in both the Life Sciences Sector Plan and NHS 10 Year Health Plan. The provisioning of a new and improved research environment will drive forward the UK's position as the best place to discover, test and benefit from genomic innovation. "This new research environment provided by Lifebit represents a significant investment in the future of genomic research. By strengthening the infrastructure that underpins secure data access and analysis, we are enabling researchers across academia and industry to generate new insights into rare conditions and cancer, and accelerating progress towards more personalised, data-driven healthcare for patients." Professor Rich Scott Chief Executive Officer of Genomics England "We are proud to work with Genomics England on the development of this next-generation research environment. By combining our technology with Genomics England's world-leading genomic data resources, we are enabling researchers to collaborate and analyse data securely at scale, with a shared ambition to drive forward scientific discovery and improve patient outcomes." Dr Maria Dunford Chief Executive Officer of Lifebit Genomics England will work with Lifebit over the next year to design, build and test the new research environment and plans to make it available to researchers in 2027. Media contact.

Pathology in Practice
Jun 9th, 2026
Genomics England Chair to step down.

Genomics England Chair to step down. * June 09, 2026 Genomics England has announced that Baroness Nicola Blackwood will step down as Chair at the end of 2026 as she comes to the end of her tenure. She has served as Chair since 2020 during which time she has supported the organisation through a period of significant progress. This includes strengthening partnerships with the NHS, enabling world-leading genomic research, and continuing to build trust in the responsible use of genomic data. Nicola will continue in the role until the end of 2026 to ensure a smooth and orderly transition. Further details on succession will be confirmed in due course. Professor Rich Scott, Chief Executive Officer, Genomics England, said: "Nicola has made an important contribution to Genomics England during her time as Chair. She has provided strong leadership and support to the organisation, helping to guide our work as we continue to deliver for participants, the NHS and the wider research community. That focus on participants and the trust they place in us will remain central as we look ahead to our next chapter. On behalf of everyone at Genomics England, I would like to thank her for her commitment and service." Baroness Nicola Blackwood commented: "It has been a privilege to serve as Chair of Genomics England and to work alongside such a dedicated and talented group of colleagues. I am very proud of the progress that has been made, particularly in strengthening the role of genomics in healthcare and research, and in maintaining the trust of those who contribute their data. Genomics England is well placed for the future, with a clear strategy and an important role at the heart of the UK's life sciences ecosystem. I would like to thank colleagues, partners and participants for their support during my time as Chair. Baroness Blackwood was appointed as the first Chair of the Health Data Research Service (HDRS) in November 2025, a new service which aims to streamline NHS data access for approved researchers to develop new medicines and therapies.

Resonate Group Incorporated
May 1st, 2026
Genomics inks partnership deal with Greywolf to assess gene datasets.

Genomics inks partnership deal with Greywolf to assess gene datasets. * May 1, 2026 Genomics inked a partnership deal with fellow U.K.-based biotech Greywolf Therapeutics to organize and evaluate ERAP enzymes and how they influence autoimmune disease risks. Fields (*) Mark are Required

Pathology In Practice
May 6th, 2025
Genomics England welcomes new Chief Technology and Product Officer

Genomics England has announced the appointment of Julian Thomas into the new role of Chief Technology and Product Officer.

StockTitan
Nov 20th, 2024
Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

WALTHAM, Mass.-(BUSINESS WIRE)- Revvity, Inc. (NYSE: RVTY), today announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical genomic initiatives across the United Kingdom.